Home > Boards > US Listed > Biotechs > Protagonist Therapeutics Inc (PTGX)

Nice. Happy trading

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Actualfactual Member Profile
 
Followed By 13
Posts 1,195
Boards Moderated 0
Alias Born 10/22/18
160x600 placeholder
Protagonist Therapeutics Reports Granting of Inducement Award PR Newswire (US) - 10/30/2020 6:27:00 PM
Protagonist Therapeutics Announces Advancement of Oral IL-23 Receptor Antagonists Program in Collaboration with Janssen PR Newswire (US) - 10/29/2020 4:30:00 PM
Protagonist Therapeutics Receives Orphan Drug Designation from the European Medicines Agency for PTG-300 in Polycythemia Vera PR Newswire (US) - 10/21/2020 7:00:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 10/2/2020 5:14:48 PM
Protagonist Therapeutics to Participate in the Jefferies Next Generation IBD Therapeutics Virtual Summit 2020 PR Newswire (US) - 9/17/2020 4:30:00 PM
Protagonist Therapeutics Reports Granting of Inducement Award PR Newswire (US) - 9/15/2020 4:48:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/11/2020 4:33:39 PM
Protagonist Therapeutics to Participate in the H.C. Wainwright 22nd Annual Global Investment Conference PR Newswire (US) - 9/10/2020 4:30:00 PM
Protagonist Therapeutics to Host PTG-300 Opportunity Update Webinar PR Newswire (US) - 9/2/2020 4:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/18/2020 5:34:10 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/18/2020 5:05:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2020 4:35:09 PM
Protagonist Appoints Sarah O'Dowd to Board of Directors PR Newswire (US) - 8/13/2020 4:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/12/2020 5:39:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2020 4:09:34 PM
Protagonist Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update PR Newswire (US) - 8/6/2020 4:01:00 PM
Hepcidin Mimetic PTG-300 Receives U.S. FDA Orphan Drug Designation for the Treatment of Polycythemia Vera PR Newswire (US) - 6/17/2020 11:07:00 PM
Protagonist Therapeutics to Participate in the BMO Prescriptions for Success Healthcare Conference PR Newswire (US) - 6/16/2020 6:05:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 6/9/2020 4:33:59 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 6/8/2020 4:05:46 PM
Protagonist Therapeutics to Present at the 25th European Hematology Association (EHA) Annual Congress PR Newswire (US) - 6/4/2020 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 6:21:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 6:20:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 6:19:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 6:17:44 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences